Assignee
VERROW PHARMACEUTICALS INC
US·1 granted patent·4 pending applications·0 citations·filing 2007–2021
Top patents by PatentIndex Score
5 records- 0159US2022096664A1Stabilized formulations containing iodinated contrast agents and cyclodextrinsVERROW PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0253US7658913B2Compositions useful for reducing nephrotoxicity and methods of use thereofVERROW PHARMACEUTICALS INC·Filed 2007·Granted Feb 9, 2010·0 cites·2 claims
- 0353US2014377185A9Stabilized formulations containing iodinated contrast agents and cyclodextrinsVERROW PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 0443US2011027390A1Methods for Reducing Cisplatin NephrotoxicityVERROW PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 0543US2011028413A1Methods of Reducing Methotrexate NephrotoxicityVERROW PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when VERROW PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →